Search
for
Sort by
Research 61–90 of 1000+
- What's new in the pathogeneses and triggering factors of bullous pemphigoid
- A Case of Generalized Hair Follicle Hamartoma Associated with Systemic Lupus Erythematosus
- Interleukin-10-deficient Mice Are Less Susceptible to the Induction of Alopecia Areata
- Diverse Role of OX40 on T Cells as a Therapeutic Target for Skin Diseases
- Cure of alopecia areata after eradication of Helicobacter pylori: a new association?
- Catalytic Antibodies in Norm and Systemic Lupus Erythematosus
- Immunology of alopecia areata
- Cancer risk in patients with alopecia areata: a nationwide population‐based matched cohort study
- CTLA4 +49AG (rs231775) and CT60 (rs3087243) gene variants are not associated with alopecia areata in a Mexican population from Monterrey Mexico
- Impending central retinal vein occlusion and granulomatous uveitis in a patient with Satoyoshi syndrome
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Ophthalmologic Comorbidities in Alopecia Areata
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Erosive Pustular Dermatosis of the Scalp in a Patient With Vitiligo Successfully Treated With Topical Antibiotics
- Alopecia areata
- Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases
- Alopecia Areata Update
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Current evaluation of amenorrhea
- Alopecia areata update
- Aldesleukin
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Epidemiology of alopecia areata in Hispanic/Latinx patients
- Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
- Lrig1-expression confers suppressive function to CD4+ cells and is essential for averting autoimmunity via the Smad2/3/Foxp3 axis
- Treatment of Satoyoshi syndrome: a systematic review
- Prostaglandins: Key players in immunomodulation of the nervous system
- Newly emerging type B insulin resistance (TBIR) during treatment with eculizumab for AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD): fatal outcome
- Herpes Zoster Precipitating First Attack of Neuromyelitis Optica along with Perinuclear Anti-Neutrophilic Cytoplasmic Antibody Positive Vasculitis